Chattanooga Oncology and Hematology Associates

Chattanooga, Tennessee 37404

0 studies enrolling now · 11 studies all time

What they study most

Breast Cancer, Colon Cancer, HER2 Positive Esophagogastric Cancer, Leukemia, Melanoma, Neoplasms, Non Small Cell Lung Cancer, Pancreatic Cancer, Prostate Cancer, Renal Cell Carcinoma

Studies at this site

• Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma — Completed
• Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal Cancer — Completed
• Neo-adjuvant Gemcitabine, Epirubicin, ABI-007 (GEA) in Locally Advanced or Inflammatory Breast Cancer — Completed
• Trastuzumab and Oxaliplatin in Patients With Metastatic Breast Cancer — Completed
• AVN944 in Combination With Gemcitabine for the Treatment of Pancreatic Cancer — Stopped early
• Denileukin Diftitox in Treating Patients With Fludarabine-Refractory B-Cell Chronic Lymphocytic Leukemia — Completed
• Comparison of Cabazitaxel/Prednisone Alone or in Combination With Custirsen for 2nd Line Chemotherapy in Prostate Cancer — Completed
• Study of 5-FU, Oxaliplatin, & Lapatinib Combined With Radiation Therapy to Treat HER2 Positive Esophagogastric Cancer — Stopped early
• Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer — Status unconfirmed
• Randomized Trial of ATN-224 and Temozolomide in Advanced Melanoma — Status unconfirmed
• A Study of the Safety and Effects of ADH-1 Given Intravenously as a Single Agent — Completed